$CLBT

[144] Cellebrite DI Ltd. SEC Filing

Cellebrite DI Ltd. (CLBT) filed a Form 144, reporting a proposed resale of 1,045 vested Restricted Share Units under an S-8 registered plan with a vesting date of May 11, 2026. The filing also detailed recent open-market sales by Marcus Jewell in February 2026, involving 1,779, 13,276, and 4,613 ordinary shares. This is a routine notice for planned employee or affiliate dispositions and has a neutral impact on the market.

Original reporting
Published May 13, 2026, 10:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 13, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CLBT
Neutral
high confidence
Mentioned
$CLBT
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$CLBTNeutralLow
01

Why it matters

The filing is unlikely to influence investor sentiment significantly; it reflects normal insider trading practices.

02

Market read

The news has minimal impact on the stock's trading dynamics, primarily relevant for compliance and insider trading transparency.

03

What to watch

Potential for future disclosures or market reactions unrelated to this filing should be monitored.

Timing: low

Background

Cellebrite DI Ltd. filed a Form 144 indicating routine insider share sales and a resale of vested RSUs, which is common corporate activity.

Company-level read

Ticker impact

$CLBTNeutralHigh confidence
Context

The filing pertains to insider share dispositions and does not indicate significant corporate changes.

Expected impact

Minimal to no immediate price movement expected

Evidence & confidence

Insider sales and planned dispositions are common and typically priced in, especially when volume is modest and routine.

Market effects

No significant sector-wide implications

Limited regional impact

Negligible

Counterpoint

Some traders might interpret insider sales as a potential signal of upcoming company concerns, but evidence here suggests routine activity.

Key entities

  • Cellebrite DI Ltd.

    A provider of digital intelligence solutions.

Related articles

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.